Krystal Biotech buy Chardan Capital
Start price
25.07.25
/
50%
€125.75
Target price
25.07.26
€186.52
Performance (%)
67.71%
Price
22:26
€210.90
Summary
This prediction is currently active. With a performance of 67.71% the BUY prediction by Chardan_Capital is a big success. This prediction currently runs until 25.07.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -1.661% | -1.661% |
| iShares Core DAX® | 1.822% | 3.926% |
| iShares Nasdaq 100 | 1.093% | -0.585% |
| iShares Nikkei 225® | 3.042% | 1.335% |
| iShares S&P 500 | 1.247% | 0.836% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $219.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
30.09%
19.12.25
19.12.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
25.47%
13.12.25
13.12.25